RecruitingNCT03797495
Study of Individuals Affected With Hypoplasminogenemia
Studying Hypoplasminogenemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Indiana Hemophilia &Thrombosis Center, Inc.
- Principal Investigator
- Amy D Shapiro, MDIndiana Hemophilia &Thrombosis Center, Inc.
- Enrollment
- 100 enrolled
- Eligibility
- All sexes
- Timeline
- 2018 – 2027
Study locations (30)
- The University of Alabama (UAB), Birmingham, Alabama, United States
- Rush University Medical Center, Chicago, Illinois, United States
- Indiana Hemophila @Thrombosis Center, Indianapolis, Indiana, United States
- University of Minnesota, Pediatric Hem/Onc & Cancer Survivorship Program, Minneapolis, Minnesota, United States
- Stony Brook University | Stony Brook Medicine, East Setauket, New York, United States
- SUNY Upstate Medical University, Pediatric Hematology/Oncology, Syracuse, New York, United States
- Wake Forest University, Winston-Salem, North Carolina, United States
- Hemophilia Center of Western Pennsylvania, Pittsburgh, Pennsylvania, United States
- Vanderbilt Children's Hematology-Oncology, Nashville, Tennessee, United States
- Cook Children's Medical Center, Forth Worth, Texas, United States
- The University of Texas Health Science Center at Houston, Houston, Texas, United States
- Seattle Children's Hospital, Seattle, Washington, United States
- Hospital Britanico Buenos Aires, Buenos Aires, Argentina
- Murdoch Children's Research Institute, The Royal Children's Hospital, Melbourne, Victoria, Australia
- Children's Health Queensland Hospital and Health Service, South Brisbane, Australia
- +15 more locations on ClinicalTrials.gov
Collaborators
Fondazione Angelo Bianchi Bonomi
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03797495 on ClinicalTrials.govOther trials for Hypoplasminogenemia
Additional recruiting or active studies for the same condition.